A Phase III, Open-Label, Randomized Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma

Name: A Phase III, Open-Label, Randomized Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma
Creator: Vivli
Published: 2026-03-27 09:30:00
License: 暂无描述

DataCite Commons2026-03-27 更新2024-07-13 收录

下载链接：

https://search.vivli.org/doiLanding/studies/00007372/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

This study will evaluate the efficacy and safety of atezolizumab in combination with bevacizumab compared with sorafenib in participants with locally advanced or metastatic Hepatocellular Carcinoma (HCC) who have received no prior systemic treatment.

提供机构：

Vivli

创建时间：

2021-08-25